Crescent Capital BDC Inc., also known as Crescent BDC, is an influential and innovative business development company that operates as a closed-end, externally managed, non-diversified management investment corporation. The company trades under the symbol 'CCAP' and is listed on the NASDAQ exchange.
Crescent BDC was first established in 2015 and is managed by Crescent Cap Advisors, a leading alternative investment firm with substantial experience and expertise in the control and non-control investment sectors. The firm, which has been in operation for over 25 years, handles assets valued at over $28 billion and boasts a team of seasoned professionals in its management wing, with industry experiences ranging from years to decades.
CCAP focuses primarily on generating current income and capital appreciation through investments in secured debt (including senior secured loans and junior secured loans) and unsecured debt, as well as equity investments. These targets are mainly lower middle market and middle-market companies that operate in a broad range of industries and are seeking capital for growth, acquisitions, recapitalizations, and buyouts.
Crescent Capital BDC Inc operates with flexibility, agility, and a disciplined investment strategy, seeking to invest mainly in first lien senior secured loans and, to a lesser extent, second lien senior secured loans. The firm's key consideration before sealing a deal is whether the transaction can add value to its diversified investment portfolio.
CCAP is revered for its strategic and calculated moves, as well as highly-skilled managerial workforces. The firm leverages the broad market reach, industry knowledge, origination capabilities and investment experience of its team members and investment advisor to identify attractive investment opportunities.
Additionally, CCAP boasts strong, transparent corporate governance, demonstrating its dedication to maintaining the trust of its shareholders, clients, and stakeholders. It follows rigorous underwriting standards that ensure it upholds the highest ethical standards in all of its investment decisions.
In sum, Crescent Capital BDC, Inc. represents a crucial player in the business development sector. It continues to make significant strides in its investment portfolio and plays a pivotal role in capital market ecosystem development by providing middle market companies with essential access to capital.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Options traders are showing significant interest in Crescent Capital BDC (CCAP) stock, with the December 18, 2026 $10.00 Put exhibiting high implied volatility, suggesting expectations of a substantial price move. Despite this, analysts currently rate CCAP as a Zacks Rank #3 (Hold), with recent earnings estimate revisions indicating a slight decrease. This high implied volatility, contrasted with the fundamental analyst outlook, could present a unique trading opportunity for options traders.
Options traders are showing significant interest in Crescent Capital BDC (CCAP) stock, particularly with the December 18, 2026 $10.00 Put, which has high implied volatility. This suggests expectations of a considerable price movement. While analysts currently rate CCAP as a Zacks Rank #3 (Hold), recent earnings estimate revisions indicate a potential for a trade development.
& Guaranty Life Insur Fidelity, a major shareholder in Crescent Capital BDC (NASDAQ:CCAP), sold 126,436 shares for over $1.3 million on September 8th, as part of a pre-arranged trading plan, reducing its stake by 3.2%. This sale occurred as CCAP shares traded near a one-year low, and the company recently missed earnings expectations, reporting $0.36 EPS against a $0.37 consensus. Despite the recent performance, analysts maintain a consensus "Hold" rating with a $13.10 price target, and the company declared a quarterly dividend of $0.34 per share, offering a 13.3% annualized yield.
Crescent Capital BDC (NASDAQ:CCAP) major shareholder Guaranty Life Insurance Fidelity sold 10,471 shares valued at $108,793.69, reducing its stake by 0.26%. This sale was part of a pre-arranged Rule 10b5-1 trading plan. The company's stock is trading near its 52-week low, and it recently declared a quarterly dividend of $0.34 per share, offering a 13.1% annualized yield.
A major shareholder of Crescent Capital BDC (NASDAQ:CCAP), Guaranty Life Insurance Fidelity, recently sold 5,011 shares of the company's stock for $51,813.74, reducing its position by 0.13%. This sale was part of several transactions in late August and early September. Crescent Capital BDC shares are near their 12-month low, and the company has a consensus "Hold" rating from analysts with a $13.10 price target.
BlackRock Inc. recently acquired 124,618 shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) in the second quarter, a stake valued at approximately $1.36 million. This purchase makes BlackRock Inc. an owner of about 0.34% of the company, with institutional investors collectively holding 49.46% of the stock. Despite this institutional interest, Crescent Capital BDC has faced challenges, including missing consensus EPS and revenue estimates, and its stock has traded near its one-year low.
Fidelity, a major shareholder in Crescent Capital BDC (NASDAQ:CCAP), sold 45,000 shares for $469,800, reducing its stake by 1.12% to 3.96 million shares. This sale, conducted under a pre-arranged Rule 10b5-1 plan, follows other recent sales and comes as CCAP shares trade near their 52-week low. The company recently missed earnings estimates but declared a quarterly dividend of $0.34 per share, offering a 13.1% yield.
Major shareholder Guaranty Life Insurance Fidelity sold 11,285 shares of Crescent Capital BDC (NASDAQ:CCAP) stock for over $118,000, reducing its ownership by 0.28%. This transaction occurred under a pre-arranged Rule 10b5-1 plan and follows several other sales by the same entity. Crescent Capital BDC shares are trading near their 12-month low, and the company recently missed earnings and revenue estimates.